|
|
Volumn 148, Issue 5, 2009, Pages 794-796
|
|
Use of recombinant interleukin-2 for intrapleural therapy of tumor-associated pleurisy
a
|
|
Author keywords
Immunotherapy; Interleukin 2; Metastatic pleurisy
|
|
Indexed keywords
ANTIPYRETIC AGENT;
CD16 ANTIGEN;
CD3 ANTIGEN;
CD4 ANTIGEN;
CD56 ANTIGEN;
CD8 ANTIGEN;
HLA DR ANTIGEN;
INTERLEUKIN 2 RECEPTOR ALPHA;
LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 3;
RECOMBINANT INTERLEUKIN 2;
RONCOLEUKIN;
UNCLASSIFIED DRUG;
ADULT;
AGED;
ARTICLE;
BREAST CANCER;
CANCER MORTALITY;
CANCER SURVIVAL;
CELL ISOLATION;
CLINICAL ARTICLE;
CONTROLLED STUDY;
DISEASE SEVERITY;
DRUG EFFICACY;
DRUG FEVER;
DRUG TOLERABILITY;
EXUDATIVE PLEURISY;
FEMALE;
FEVER;
FLOW CYTOMETRY;
FLUORESCENCE ACTIVATED CELL SORTING;
HUMAN;
IMMUNOPHENOTYPING;
KIDNEY CANCER;
LUNG CANCER;
MALE;
MONONUCLEAR CELL;
OVARY CANCER;
QUALITY OF LIFE;
RELAPSE;
SPIRAL COMPUTER ASSISTED TOMOGRAPHY;
THORACOSCOPY;
THORAX RADIOGRAPHY;
THORAX SURGERY;
TREATMENT OUTCOME;
ADULT;
AGED;
FEMALE;
HUMANS;
IMMUNOPHENOTYPING;
INJECTIONS, INTRALESIONAL;
INTERLEUKIN-2;
MALE;
MIDDLE AGED;
NEOPLASMS;
PLEURISY;
TREATMENT OUTCOME;
|
|
EID: 77952094824
PISSN: 00074888
EISSN: None
Source Type: Journal
DOI: 10.1007/s10517-010-0818-2 Document Type: Article |
|
Times cited : (4)
|
|
References (12)
|
